Integrin Regulation of Non-apoptotic Death in Breast Cancer

整合素对乳腺癌非凋亡死亡的调节

基本信息

项目摘要

Summary This proposal will examine the regulation and role of ferroptosis in epithelial and carcinoma biology. Ferroptosis involves the accumulation of intracellular reactive oxygen species (ROS) leading to inactivation of the lipid repair enzyme glutathione peroxidase 4 (GPX4) and the consequent increase in lipid peroxides that causes cell death. Data obtained reveal that extracellular matrix (ECM)-detached mammary epithelial and breast carcinoma cells undergo ferroptosis specifically in the absence of a6b4. Also, ECM-detached cells that cluster are prone to ferroptosis in the absence of a6b4. In contrast, single cells undergo apoptosis if a6b4 expression is depleted. The ability of a6b4 to signal an anti-ferroptotic response in ECM-detached cells appears to be dependent on F-actin-rich, cell-cell complexes and that a6b4 may nucleate the formation of these complexes, which have been termed ‘ferroptosis resistance complexes’. It is hypothesized that a6b4 signaling under these conditions buffers an increase in lipid peroxidation that occurs as a result of ECM detachment by maintaining the expression of GPX4, a lipid peroxidase, enabling the evasion of ferroptosis. It is proposed that the mechanism involves the ability of a6b4 signaling to stabilize GPX4 mRNA and prevents its decay in stress conditions by promoting N6-methyladenosine (m6A) RNA de-methylation. The first aim will investigate how a6b4 signaling is activated in ECM-detached cells and its role in the formation of ferroptosis resistance complexes. The second aim will determine that a6b4 signaling impacts the stability of GPX4 and other mRNAs in response to ECM-detachment. This aim will also involve identifying the spectrum of mRNAs that are stabilized by m6A-de-methylation upon ECM-detachment. The final aim will investigate the significance of a6b4 regulation of GPX4 and evasion of ferroptosis in breast cancer using mouse models. This aim will involve an unbiased approach to assessing the contribution of GPX4 to breast tumorigenesis and progression by conditional deletion in a transgenic mouse model of triple-negative breast cancer. Analysis of these mice will enable an assessment of the contribution of GPX4 to tumor initiation, growth and metastasis, including circulating tumor cells, and its role in the evasion of ferroptosis in vivo. The novel and unanticipated hypotheses to be addressed have the potential to open a new field of investigation with significant implications for our understanding of both ferroptosis and tumor biology that could benefit the design and development of therapies to impede metastasis. !
总结

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Protocol for the separation of extracellular vesicles by ultracentrifugation from in vitro cell culture models.
  • DOI:
    10.1016/j.xpro.2021.100303
  • 发表时间:
    2021-03-19
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Chhoy P;Brown CW;Amante JJ;Mercurio AM
  • 通讯作者:
    Mercurio AM
Prominin2 Drives Ferroptosis Resistance by Stimulating Iron Export.
  • DOI:
    10.1016/j.devcel.2019.10.007
  • 发表时间:
    2019-12-02
  • 期刊:
  • 影响因子:
    11.8
  • 作者:
    Brown CW;Amante JJ;Chhoy P;Elaimy AL;Liu H;Zhu LJ;Baer CE;Dixon SJ;Mercurio AM
  • 通讯作者:
    Mercurio AM
Targeting prominin2 transcription to overcome ferroptosis resistance in cancer.
  • DOI:
    10.15252/emmm.202013792
  • 发表时间:
    2021-08-09
  • 期刊:
  • 影响因子:
    11.1
  • 作者:
    Brown CW;Chhoy P;Mukhopadhyay D;Karner ER;Mercurio AM
  • 通讯作者:
    Mercurio AM
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Arthur M Mercurio其他文献

Arthur M Mercurio的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Arthur M Mercurio', 18)}}的其他基金

Novel Therapeutic Approaches for Aggressive Prostate Cancer
侵袭性前列腺癌的新治疗方法
  • 批准号:
    10734381
  • 财政年份:
    2023
  • 资助金额:
    $ 37.55万
  • 项目类别:
Integrin Regulation of Non-apoptotic Death in Breast Cancer
整合素对乳腺癌非凋亡死亡的调节
  • 批准号:
    10196990
  • 财政年份:
    2018
  • 资助金额:
    $ 37.55万
  • 项目类别:
Nanosensor-Based Phenotypic Screening for Precision Therapy of Cancer Stem Cells
基于纳米传感器的表型筛选用于癌症干细胞的精准治疗
  • 批准号:
    9371612
  • 财政年份:
    2017
  • 资助金额:
    $ 37.55万
  • 项目类别:
Integrin splicing and cancer stem cell fate
整合素剪接和癌症干细胞命运
  • 批准号:
    9055381
  • 财政年份:
    2015
  • 资助金额:
    $ 37.55万
  • 项目类别:
VEGF Signaling in Mammary Tumorigenesis
乳腺肿瘤发生中的 VEGF 信号转导
  • 批准号:
    8406744
  • 财政年份:
    2012
  • 资助金额:
    $ 37.55万
  • 项目类别:
Mechanisms of Carcinoma Differentiation and Invasion
癌分化和侵袭的机制
  • 批准号:
    8658042
  • 财政年份:
    2012
  • 资助金额:
    $ 37.55万
  • 项目类别:
Mechanisms of Carcinoma Differentiation and Invasion
癌分化和侵袭的机制
  • 批准号:
    8507623
  • 财政年份:
    2012
  • 资助金额:
    $ 37.55万
  • 项目类别:
VEGF Signaling in Mammary Tumorigenesis
乳腺肿瘤发生中的 VEGF 信号转导
  • 批准号:
    8507653
  • 财政年份:
    2012
  • 资助金额:
    $ 37.55万
  • 项目类别:
VEGF signaling in Mammary Tumorigenesis
乳腺肿瘤发生中的 VEGF 信号传导
  • 批准号:
    10152521
  • 财政年份:
    2012
  • 资助金额:
    $ 37.55万
  • 项目类别:
VEGF signaling in Mammary Tumorigenesis
乳腺肿瘤发生中的 VEGF 信号传导
  • 批准号:
    9922868
  • 财政年份:
    2012
  • 资助金额:
    $ 37.55万
  • 项目类别:

相似海外基金

Enhancing gamete cryoprotective properties of graphene oxide by dual functionalization with antioxidants and non-penetrating cryoprotectant molecules
通过抗氧化剂和非渗透性冷冻保护剂分子的双重功能化增强氧化石墨烯的配子冷冻保护特性
  • 批准号:
    24K18002
  • 财政年份:
    2024
  • 资助金额:
    $ 37.55万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
SBIR Phase I: Sustainable antioxidants for industrial process fluids
SBIR 第一阶段:工业过程流体的可持续抗氧化剂
  • 批准号:
    2222215
  • 财政年份:
    2023
  • 资助金额:
    $ 37.55万
  • 项目类别:
    Standard Grant
Development of a new bone augmentation method that enables long-term survival and long-term functional expression of transplanted cells by antioxidants
开发一种新的骨增强方法,通过抗氧化剂使移植细胞能够长期存活和长期功能表达
  • 批准号:
    23K09272
  • 财政年份:
    2023
  • 资助金额:
    $ 37.55万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Non-Invasive Probing Cellular Oxidative Stress and Antioxidants Therapeutic Effectiveness
非侵入性探测细胞氧化应激和抗氧化剂的治疗效果
  • 批准号:
    10652764
  • 财政年份:
    2023
  • 资助金额:
    $ 37.55万
  • 项目类别:
Mitochondria-targeting Novel Cationic Hydrazone Antioxidants for the Treatment of Preeclampsia
线粒体靶向新型阳离子腙抗氧化剂用于治疗先兆子痫
  • 批准号:
    10730652
  • 财政年份:
    2023
  • 资助金额:
    $ 37.55万
  • 项目类别:
Latent Antioxidants for Environmentally Responsible Polymer Formulations
用于环保聚合物配方的潜在抗氧化剂
  • 批准号:
    RGPIN-2018-04107
  • 财政年份:
    2022
  • 资助金额:
    $ 37.55万
  • 项目类别:
    Discovery Grants Program - Individual
Contribution of antioxidants to regeneration of rotator cuff insertion
抗氧化剂对肩袖插入再生的贡献
  • 批准号:
    22K16720
  • 财政年份:
    2022
  • 资助金额:
    $ 37.55万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of different doses of antioxidants(Vitamin E) intake on exercise induced oxidative stress, antioxidative capacity and chronic inflammation
不同剂量抗氧化剂(维生素E)摄入对运动引起的氧化应激、抗氧化能力和慢性炎症的影响
  • 批准号:
    22K11609
  • 财政年份:
    2022
  • 资助金额:
    $ 37.55万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Polyunsaturated fatty acid (PUFA), inflammation and antioxidants
多不饱和脂肪酸 (PUFA)、炎症和抗氧化剂
  • 批准号:
    RGPIN-2019-05674
  • 财政年份:
    2022
  • 资助金额:
    $ 37.55万
  • 项目类别:
    Discovery Grants Program - Individual
Suppressed methemoglobin formation of artificial red cell by liposomal antioxidants and its mechanism.
脂质体抗氧化剂抑制人工红细胞高铁血红蛋白形成及其机制
  • 批准号:
    22K12824
  • 财政年份:
    2022
  • 资助金额:
    $ 37.55万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了